Expert insight 26 Apr 2013

Celebrating World Intellectual Property Day

Today we celebrate the World Intellectual Property Day to praise the invaluable contributions made by innovators across the globe. Since the dawn of time, mankind has applied innovation to solve problems and live better, healthier and more plentiful lives. Apart from human creativity and passion, IP has been one of the most powerful forces fostering...

Read more
Statement 25 Apr 2013

UNODC Commission on crime prevention and criminal justice, 22nd session

UNODC Commission on Crime Prevention and Criminal Justice, 22nd session IFPMA statement under item 7 of the provisional agenda on World crime trends and emerging issues and responses in the field of crime prevention and criminal justice Countering fraudulent medicines, in particular their trafficking Delivered by Cyntia Genolet, Policy Analyst, Public Affairs and Global Health...

Read more
Expert insight 25 Apr 2013

Fake Medicines – a Hurdle on our Way to Beating Malaria

Results from the UN Decade to Roll Back Malaria tell us global malaria deaths have been reduced by 38% and that 10 countries on the African continent—and most endemic countries in other regions—halved malaria cases and deaths. This means the lives of 1.1 million children under five years have been saved in the last decade....

Read more
Press release 18 Apr 2013

Vaccine experts recommend practical actions to support vaccine innovation and access around the world

Peer-reviewed article in Vaccine addresses the 4As of vaccine access – availability, affordability, adoption and alliances Paper’s recommendations offer insights on how to achieve the Decade of Vaccine’s goal of 90% global vaccine coverage by 2020. Increased vaccine awareness, predictable demand, and sustainable financing among 26 expert recommendations to support vaccine access and innovation A...

Read more
Expert insight 8 Apr 2013

Working to dispel the misperception that incremental innovation is trivial

Incremental innovation is the term used for subsequent improvements made to a “first-in-class” medicine, but it is often incorrectly associated with prolonging the patent term for an existing medicine which is not the case. Indeed, once the patent exclusivity period of the existing “first-in-class” patent has expired, any firm, regardless of patenting related to improvements...

Read more
Infographic 8 Apr 2013

Innovative vaccines companies and the Decade of vaccines

Read more
Infographic 8 Apr 2013

Vaccine research and development

Read more
Report 7 Apr 2013

Incremental innovation: Adapting to patient needs

Read more
Infographic 2 Apr 2013

Health by the numbers: results of the 2011 IFPMA wellness survey

Read more
Infographic 2 Apr 2013

A vibrant pipeline for unmet medical needs

Read more
External study 1 Apr 2013

Addressing the gaps in global policy and research for non-communicable diseases

Read more
Expert insight 27 Mar 2013

Launch of Global Health Matters blog

Welcome to IFPMA’s Global Health Matters blog. We are launching this forum to foster exchange and dialog on health topics that matter to all of us. As you know, the issues and challenges that organizations and individuals in the global health community face daily are plentiful, complex, and ever-changing. We believe a good way for...

Read more